Ex vivo screening of prospective peptide drugs: new approaches.
Andreeva
L A
LA
Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia.
Mezentseva
M V
MV
Nagaev
I Yu
IY
Shapoval
I M
IM
Shcherbenko
V E
VE
Potapova
L A
LA
Russu
L I
LI
Narovlyansky
A N
AN
Ershov
F I
FI
Myasoedov
N F
NF
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology; D000328:Adult; D002690:Chlamydia Infections / Q000188:drug therapy; D016207:Cytokines / Q000096:biosynthesis*; D003586:Cytomegalovirus Infections / Q000188:drug therapy; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D006526:Hepatitis C / Q000188:drug therapy; D006558:Herpes Genitalis / Q000188:drug therapy; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy; D009175:Mycoplasma Infections / Q000188:drug therapy; D009842:Oligopeptides / Q000494:pharmacology* / Q000627:therapeutic use; D010446:Peptide Fragments / Q000494:pharmacology*; D012333:RNA, Messenger / Q000378:metabolism; D012141:Respiratory Tract Infections / Q000188:drug therapy; D018417:Th1 Cells / Q000187:drug effects / Q000378:metabolism*; D014376:Tuberculosis / Q000188:drug therapy
D016207:Cytokines; D009842:Oligopeptides; D010446:Peptide Fragments; D012333:RNA, Messenger; C048487:ACTH (4-7), Pro-Gly-Pro-; D000324:Adrenocorticotropic Hormone; C100827:TP 7